Shirley J Shao, Lucy J Fu, Llyke Ching, Katelin P Kramer, Nasim C Sobhani
{"title":"妊娠期糖尿病不同筛查策略的产妇和新生儿结局:一项回顾性队列研究","authors":"Shirley J Shao, Lucy J Fu, Llyke Ching, Katelin P Kramer, Nasim C Sobhani","doi":"10.1080/14767058.2025.2467996","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the effect of an expanded gestational diabetes mellitus (GDM) screening strategy on perinatal outcomes.</p><p><strong>Methods: </strong>This retrospective cohort study included gravidas screened for GDM at a single academic center. The \"before\" cohort (estimated due dates (EDD) March 2018-April 2019) was screened using the standard 2-step method. The \"after\" cohort (EDD November 2019-July 2023) was screened using an expanded strategy that included the potential for GDM diagnosis based on 1-2 weeks of home glucose monitoring following isolated fasting hyperglycemia on the 3-hour glucose tolerance test (GTT). The primary outcomes were primary cesarean delivery (PCD) and neonatal intensive care unit (NICU) admission. Binomial regression and Kruskal Wallis tests were used to compare perinatal outcomes between the two cohorts in the general population and in a subgroup of those with isolated fasting hyperglycemia.</p><p><strong>Results: </strong>Outcomes for the \"before\" cohort (<i>n</i> = 1,733) were compared with those in the \"after\" cohort (<i>n</i> = 6,280). In the general population, A2GDM incidence increased after expansion of the screening protocol (4.8% vs. 6.4%, RR 1.34, 95% CI 1.07-1.69), but PCD and NICU admission rates were unchanged. In the subgroup of patients with isolated fasting hyperglycemia (<i>n</i> = 233), there was a significant increase in the incidence of any GDM (12.5 vs. 46.0%, RR 3.68, 95% CI 1.95-6.93) and A2GDM (8.3% vs. 37.3%, RR 4.47, 95% CI 2.03-9.87). There was no difference in PCD between cohorts, but NICU admission increased significantly in the \"after\" cohort (8.3% vs 22.4%, RR 2.68, 95% CI 1.18-6.08) in this subgroup.</p><p><strong>Conclusion: </strong>An expanded approach to GDM diagnosis using home blood glucose monitoring following isolated fasting hyperglycemia on 3-hour GTT was associated with increased A2GDM incidence but no improvements in primary maternal or neonatal outcomes. In the absence of clinical benefit, we do not recommend widespread implementation of this expanded strategy.</p>","PeriodicalId":50146,"journal":{"name":"Journal of Maternal-Fetal & Neonatal Medicine","volume":"38 1","pages":"2467996"},"PeriodicalIF":1.7000,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Maternal and neonatal outcomes with different screening strategies for gestational diabetes mellitus: a retrospective cohort study.\",\"authors\":\"Shirley J Shao, Lucy J Fu, Llyke Ching, Katelin P Kramer, Nasim C Sobhani\",\"doi\":\"10.1080/14767058.2025.2467996\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>To evaluate the effect of an expanded gestational diabetes mellitus (GDM) screening strategy on perinatal outcomes.</p><p><strong>Methods: </strong>This retrospective cohort study included gravidas screened for GDM at a single academic center. The \\\"before\\\" cohort (estimated due dates (EDD) March 2018-April 2019) was screened using the standard 2-step method. The \\\"after\\\" cohort (EDD November 2019-July 2023) was screened using an expanded strategy that included the potential for GDM diagnosis based on 1-2 weeks of home glucose monitoring following isolated fasting hyperglycemia on the 3-hour glucose tolerance test (GTT). The primary outcomes were primary cesarean delivery (PCD) and neonatal intensive care unit (NICU) admission. Binomial regression and Kruskal Wallis tests were used to compare perinatal outcomes between the two cohorts in the general population and in a subgroup of those with isolated fasting hyperglycemia.</p><p><strong>Results: </strong>Outcomes for the \\\"before\\\" cohort (<i>n</i> = 1,733) were compared with those in the \\\"after\\\" cohort (<i>n</i> = 6,280). In the general population, A2GDM incidence increased after expansion of the screening protocol (4.8% vs. 6.4%, RR 1.34, 95% CI 1.07-1.69), but PCD and NICU admission rates were unchanged. In the subgroup of patients with isolated fasting hyperglycemia (<i>n</i> = 233), there was a significant increase in the incidence of any GDM (12.5 vs. 46.0%, RR 3.68, 95% CI 1.95-6.93) and A2GDM (8.3% vs. 37.3%, RR 4.47, 95% CI 2.03-9.87). There was no difference in PCD between cohorts, but NICU admission increased significantly in the \\\"after\\\" cohort (8.3% vs 22.4%, RR 2.68, 95% CI 1.18-6.08) in this subgroup.</p><p><strong>Conclusion: </strong>An expanded approach to GDM diagnosis using home blood glucose monitoring following isolated fasting hyperglycemia on 3-hour GTT was associated with increased A2GDM incidence but no improvements in primary maternal or neonatal outcomes. In the absence of clinical benefit, we do not recommend widespread implementation of this expanded strategy.</p>\",\"PeriodicalId\":50146,\"journal\":{\"name\":\"Journal of Maternal-Fetal & Neonatal Medicine\",\"volume\":\"38 1\",\"pages\":\"2467996\"},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2025-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Maternal-Fetal & Neonatal Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/14767058.2025.2467996\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/2/20 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"OBSTETRICS & GYNECOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Maternal-Fetal & Neonatal Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/14767058.2025.2467996","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/20 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
目的:评价扩大妊娠期糖尿病(GDM)筛查策略对围产儿结局的影响。方法:本回顾性队列研究纳入了在单一学术中心进行GDM筛查的孕妇。使用标准的两步法筛选“前”队列(预计预产期(EDD) 2018年3月至2019年4月)。“之后”队列(EDD 2019年11月- 2023年7月)使用扩展策略进行筛选,其中包括基于3小时葡萄糖耐量试验(GTT)中孤立空腹高血糖后1-2周的家庭血糖监测来诊断GDM的可能性。主要结局为首次剖宫产(PCD)和新生儿重症监护病房(NICU)入院。二项回归和Kruskal Wallis检验用于比较普通人群和孤立性空腹高血糖亚组中两个队列的围产期结局。结果:将“治疗前”队列(n = 1733)的结果与“治疗后”队列(n = 6280)的结果进行比较。在普通人群中,扩大筛查方案后,A2GDM发病率增加(4.8% vs. 6.4%, RR 1.34, 95% CI 1.07-1.69),但PCD和NICU入院率不变。在孤立空腹高血糖患者亚组(n = 233)中,任何GDM(12.5比46.0%,RR 3.68, 95% CI 1.95-6.93)和A2GDM(8.3%比37.3%,RR 4.47, 95% CI 2.03-9.87)的发病率显著增加。各组间PCD无差异,但“术后”组NICU入院率显著增加(8.3% vs 22.4%, RR 2.68, 95% CI 1.18-6.08)。结论:在单独空腹高血糖3小时GTT后使用家庭血糖监测来诊断GDM的扩展方法与A2GDM发病率增加相关,但对原发性产妇或新生儿结局没有改善。在缺乏临床益处的情况下,我们不建议广泛实施这一扩展策略。
Maternal and neonatal outcomes with different screening strategies for gestational diabetes mellitus: a retrospective cohort study.
Objective: To evaluate the effect of an expanded gestational diabetes mellitus (GDM) screening strategy on perinatal outcomes.
Methods: This retrospective cohort study included gravidas screened for GDM at a single academic center. The "before" cohort (estimated due dates (EDD) March 2018-April 2019) was screened using the standard 2-step method. The "after" cohort (EDD November 2019-July 2023) was screened using an expanded strategy that included the potential for GDM diagnosis based on 1-2 weeks of home glucose monitoring following isolated fasting hyperglycemia on the 3-hour glucose tolerance test (GTT). The primary outcomes were primary cesarean delivery (PCD) and neonatal intensive care unit (NICU) admission. Binomial regression and Kruskal Wallis tests were used to compare perinatal outcomes between the two cohorts in the general population and in a subgroup of those with isolated fasting hyperglycemia.
Results: Outcomes for the "before" cohort (n = 1,733) were compared with those in the "after" cohort (n = 6,280). In the general population, A2GDM incidence increased after expansion of the screening protocol (4.8% vs. 6.4%, RR 1.34, 95% CI 1.07-1.69), but PCD and NICU admission rates were unchanged. In the subgroup of patients with isolated fasting hyperglycemia (n = 233), there was a significant increase in the incidence of any GDM (12.5 vs. 46.0%, RR 3.68, 95% CI 1.95-6.93) and A2GDM (8.3% vs. 37.3%, RR 4.47, 95% CI 2.03-9.87). There was no difference in PCD between cohorts, but NICU admission increased significantly in the "after" cohort (8.3% vs 22.4%, RR 2.68, 95% CI 1.18-6.08) in this subgroup.
Conclusion: An expanded approach to GDM diagnosis using home blood glucose monitoring following isolated fasting hyperglycemia on 3-hour GTT was associated with increased A2GDM incidence but no improvements in primary maternal or neonatal outcomes. In the absence of clinical benefit, we do not recommend widespread implementation of this expanded strategy.
期刊介绍:
The official journal of The European Association of Perinatal Medicine, The Federation of Asia and Oceania Perinatal Societies and The International Society of Perinatal Obstetricians. The journal publishes a wide range of peer-reviewed research on the obstetric, medical, genetic, mental health and surgical complications of pregnancy and their effects on the mother, fetus and neonate. Research on audit, evaluation and clinical care in maternal-fetal and perinatal medicine is also featured.